Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$49.82 USD
+1.85 (3.86%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $49.77 -0.05 (-0.10%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Earnings News For RYTM
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
-
Rhythm Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Update
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
-
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
-
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q1 Earnings Expected to Decline
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Misses Revenue Estimates
-
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
-
Rhythm Pharmaceuticals, Inc. (RYTM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates
-
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
-
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
-
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Update
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
-
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
-
Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Lags Revenue Estimates
-
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
-
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q3 Earnings Expected to Decline
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates
-
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
-
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy?